Experiences of People with Type 2 Diabetes and Healthcare Professionals with Once-Weekly Insulin Efsitora Alfa in QWINT Phase 3 Trials: Qualitative In-Trial Interviews [0.03%]
一项3期QWINT试验中针对接受每周一次的基础胰岛素efegliafaa治疗的2型糖尿病患者和医护专业人员进行定性试验访谈的经历
William H Polonsky,Emma L Low,Carla Dias-Barbosa et al.
William H Polonsky et al.
Background: People with type 2 diabetes (PwD) and healthcare professionals (HCPs) often perceive daily basal insulin regimens as burdensome, and many PwD requiring basal insulin fail to achieve glycemic targets. Once-week...
Probabilistic Attribute Presentation in Discrete Choice Experiments: A Scoping Review of Current Practice [0.03%]
离散选择实验中概率属性呈现的范围性综述研究当前实践
Gabriela S Fernandez,Saudamini Oke,Matt Quaife
Gabriela S Fernandez
Objectives: There is growing interest in how probability information is framed and presented in health-related discrete choice experiments (DCEs), given evidence that presentation formats can influence respondents' choice...
Expanding Access to Oral Contraceptive Pills: Do Consumers Prefer Over-the-Counter Availability? [0.03%]
口服避孕药的获取渠道扩展：消费者是否更倾向于非处方药形式？
Zobaida Ahmed,Bonny Parkinson,Kompal Sinha et al.
Zobaida Ahmed et al.
Background: Expanding access to oral contraceptive pills (OCPs) through over-the-counter (OTC) reclassification may reduce barriers to contraception, but Australian consumer preferences for OTC OCP access remain poorly un...
Patient Preferences and Treatment Decision Drivers in IDH-Mutant Grade 2 Glioma: An International Discrete Choice Experiment [0.03%]
国际IDH突变二级胶质瘤患者偏好及治疗决策驱动因素调查：离散选择实验研究
Ashley Parham Ghiaseddin,Kismet Hossain-Ibrahim,Antje Wick et al.
Ashley Parham Ghiaseddin et al.
Background: Grade 2 isocitrate dehydrogenase (IDH)-mutant (mIDH) glioma imposes significant health-related quality of life (HRQoL) and economic burden. Ob...
Responsiveness of the EQ-5D-Y-5L Parent-Proxy Version Among Children with Juvenile Idiopathic Arthritis [0.03%]
评估儿童青少年类风湿关节炎患者父母版本EQ-5D-Y-5L灵敏度的研究
Deborah A Marshall,Jiabi Wen,Gillian R Currie et al.
Deborah A Marshall et al.
Background: Valid and reliable health-related quality of life (HRQoL) instruments are needed in clinical practice to quantify the burden of juvenile idiopathic arthritis (JIA) and capture changes in health over time. We e...
Treatment Preferences in Adult Patients with Type 2 and Type 3 Spinal Muscular Atrophy: Evidence from a Discrete Choice Experiment in China [0.03%]
中国2型和3型脊髓性肌萎缩症成人患者治疗偏好证据（基于离散选择实验）
Jiaqi Yuan,Shunping Li,Lei Dou et al.
Jiaqi Yuan et al.
Introduction: Spinal muscular atrophy (SMA) is a rare autosomal recessive hereditary neuromuscular disease that leads to progressive muscle weakness and atrophy. Available treatments differ significantly in terms of effec...
Severity or Incidence: Labeling Side-Effect Attributes in Discrete Choice Experiments [0.03%]
严重性或发生率：离散选择实验中副作用属性的标签化问题
Stella Maria Marceta,Esther Wilhelmina de Bekker-Grob,Tom Van Ourti et al.
Stella Maria Marceta et al.
Introduction: While medicine regulation in many countries requires prescription drug labels to classify side effects based on their incidence, when eliciting preferences of patients, most discrete choice experiments (DCEs...
Patients' Preferences for Surgical Procedures in Hidradenitis Suppurativa: A Discrete Choice Experiment [0.03%]
汗腺炎患者的手术治疗偏好：一种选择实验的方法
Katja C Heinz,Emily G Summers,Charlotte Beaudart et al.
Katja C Heinz et al.
Background and objective: Hidradenitis suppurativa is a burdensome chronic inflammatory skin disorder. While surgery can be essential for many patients, preferences and values regarding surgery are insufficiently characte...
Correction: Public Preferences and Willingness to Pay for a Multidisciplinary Colorectal and Pelvic Reconstruction Service [0.03%]
关于纠正公共偏好和多学科结直肠和盆底重建服务的支付意愿之间的关系
Tianxin Pan,Misel Trajanovska,Yan Meng et al.
Tianxin Pan et al.
Published Erratum
The patient. 2026 Apr 22. DOI:10.1007/s40271-026-00816-3 2026
Experiences of Migraine and Erenumab Treatment in Japan: Qualitative Interviews with Clinical Trial Participants [0.03%]
日本偏头痛患者口服Erenumab治疗的体验——定性分析临床试验参与者的观点
Carla Dias-Barbosa,Hisaka Igarashi,Ashley Duenas et al.
Carla Dias-Barbosa et al.
Background: In Japan, migraine is estimated to affect 6-8.6% of the population, and the burden of migraine and barriers to migraine care are substantial. Although new preventive treatments are available for migraine, ther...